title: Increased mortality risk in congestive heart failure patients with comorbid sleep apnoea: 10-year follow up.
abstract: We aimed to determine the mortality rates of a congestive heart failure (CHF) research cohort during a 10-year follow up and compare survival between those with CHF only (controls), CHF and central sleep apnoea, and CHF and obstructive sleep apnoea. There was a significant detriment of survival in patients with CHF/central sleep apnoea compared with both CHF/obstructive sleep apnoea patients (mean survival time difference 3.8 years, P = 0.005) and controls (mean survival time difference 4.0 years, P = 0.01).
authors.affiliation: WellSleep Sleep Investigation Centre, Department of Medicine, University of Otago, Wellington, New Zealand. jessie.bakker@otago.ac.nz
authors.forename: J P
authors.initials: JP
authors.lastname: Bakker
authors.forename: A J
authors.initials: AJ
authors.lastname: Campbell
authors.forename: A M
authors.initials: AM
authors.lastname: Neill
mesh_terms: D000368:Aged; D002423:Cause of Death; D015897:Comorbidity; D045422:Continuous Positive Airway Pressure / Q000706:statistics & numerical data; D005260:Female; D005500:Follow-Up Studies; D005541:Forced Expiratory Volume; D006333:Heart Failure / Q000401:mortality*; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D009520:New Zealand / Q000453:epidemiology; D018401:Sample Size; D012720:Severity of Illness Index; D020182:Sleep Apnea, Central / Q000453:epidemiology* / Q000628:therapy; D020181:Sleep Apnea, Obstructive / Q000453:epidemiology* / Q000628:therapy; D013318:Stroke Volume; D014797:Vital Capacity